(18)F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer. Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, et al. J Nucl Med 2024 Mar 21:jnumed.123.267186. doi: 10.2967/jnumed.123.267186.

Read + Share

Amedeo Smart

Independent Medical Education

Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, et al. (18)F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer. J Nucl Med 2024 Mar 21:jnumed.123.267186. doi: 10.2967/jnumed.123.267186.
PMID: 38514081